Login / Signup

Implant treatment in pharmacologically immunosuppressed liver transplant patients: A prospective-controlled study.

Víctor ParedesRosa María López-PintorJesús TorresJuan Carlos de VicenteMariano SanzGonzalo Hernández
Published in: Clinical oral implants research (2017)
Pharmacologically immunosuppression in liver transplant patients was not a risk factor for implant failure, nor for the incidence of peri-implant diseases. Liver transplant is not a contraindication for dental implant treatment, although these patients should be carefully monitored during follow-up care.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • healthcare
  • prognostic factors
  • patient reported outcomes
  • health insurance
  • replacement therapy